硝酸萘甲唑啉

硝酸萘甲唑啉用途

萘唑啉(萘唑啉)硝酸盐是一种α-肾上腺素能受体激动剂。硝酸萘唑啉可降低血管通透性,促进血管收缩。硝酸萘唑啉可降低炎症因子(TNF-α、IL-1β和IL-6)、细胞因子(IFN-γ和IL-4)、IgE、GMCSF和NGF的水平硝酸萘唑啉可用于非细菌性结膜炎研究[1][2]。

点击显示

硝酸萘甲唑啉名称

[ CAS 号 ]:
5144-52-5

[ 中文名 ]:
硝酸萘甲唑啉

[ 英文名 ]:
Naphazoline nitrate

[中文别名 ]:

[英文别名 ]:

2-(1-Naphthylmethyl)-2-imidazoline nitrate
naphtyzin
EINECS 225-915-4
MFCD00014316
2-imidazoline, 2-(1-naphthylmethyl)-, mononitrate
2-(1-Naphthylmethyl)imidazoline nitrate
NAPHAZOLINI NITRAS
privinenitrate
Privina
Naphazoline nitrate

硝酸萘甲唑啉生物活性

[ 描述 ]:

[ 相关类别 ]:

研究领域 >> 心血管疾病

信号通路 >> 免疫及炎症 >> 白细胞介素相关

信号通路 >> G 蛋白偶联受体/G 蛋白 >> 肾上腺素能受体

研究领域 >> 炎症/免疫

信号通路 >> 蛋白酪氨酸激酶 >> VEGFR

[ 靶点 ]

TNF-α

IL-1β

IL-6

IL-4

[体内研究]

硝酸萘唑啉(0.2 mg/kg,10µl/眼；IP,一次)降低组胺或抗原诱导的小鼠结膜血管通透性,并通过对炎症、NGF和VEGF的影响降低小鼠结膜炎[1]。动物模型：雌性野生型BALB/c小鼠(4-5周,18±2 g,n=8/组,使用组胺或抗原(卵清蛋白)建立过敏性结膜炎小鼠模型)[1]剂量：0.2 mg/mL,10µl/眼给药：腹腔注射(IP),一次结果：显著抑制组胺或抗原诱导的结膜血管通透性高的小鼠结膜色素渗漏。降低炎症反应和IL-1β、IL-6、IFN-γ和IL-4的水平。降低抗原诱导的结膜血管通透性高的小鼠中IgE、GMCSF、NGF和VEGF的水平。

[参考文献]

[1]. Quan L, et, al. Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. Mol Med Rep. 2016 Apr;13(4):3319-25.

[2]. Yamaguchi I, et, al. Central and peripheral adrenergic mechanisms regulating gastric secretion in the rat. J Pharmacol Exp Ther. 1977 Oct;203(1):125-31.

硝酸萘甲唑啉物理化学性质

[ 沸点 ]:
440.5ºC at 760mmHg

[ 熔点 ]:
167-170 °C

[ 分子式 ]:
C₁₄H₁₅N₃O₃

[ 分子量 ]:
273.287

[ 闪点 ]:
220.2ºC

[ 精确质量 ]:
273.111328

[ PSA ]:
90.44000

[ LogP ]:
2.32390

[ 外观性状 ]:
白色固体

[ 储存条件 ]:
室温

硝酸萘甲唑啉毒性和生态

CHEMICAL IDENTIFICATION

RTECS NUMBER :: NJ4376000

CHEMICAL NAME :: 2-Imidazoline, 2-(1-naphthylmethyl)-, mononitrate

CAS REGISTRY NUMBER :: 5144-52-5

LAST UPDATED :: 199512

DATA ITEMS CITED :: 9

MOLECULAR FORMULA :: C14-H14-N2.H-N-O3

MOLECULAR WEIGHT :: 273.32

WISWESSER LINE NOTATION :: L66J B1- BT5M CN BUTJ &..H..N-O3

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1260 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 21,204,1966

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 385 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,539,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 265 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 21,204,1966

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 66 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 21,204,1966

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 170 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,539,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 13200 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 21,204,1966

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 50 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,539,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 950 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,539,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rabbit

DOSE/DURATION :: 800 ug/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,539,1982

点击显示

硝酸萘甲唑啉安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H302

[ 警示性声明 ]:
P301 + P312 + P330

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xn:Harmful;

[ 风险声明 (欧洲) ]:
R22

[ 安全声明 (欧洲) ]:
S22-S36/37

[ 危险品运输编码 ]:
3249

[ WGK德国 ]:
3

[ RTECS号 ]:
NJ4376000

[ 包装等级 ]:
III

[ 危险类别 ]:
6.1(b)

[ 海关编码 ]:
2933290090

硝酸萘甲唑啉海关

[ 海关编码 ]: 2934999090

[ 中文概述 ]:
2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%